Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): A stratified, biopsy-driven, multi-centre, randomised, open label, controll... by Humby, F, Durez, P, Buch, MH, Lewis, M, Rizvi, H, Rivellese, F, Nerviani, A, Giorli, G, Mahto, A, Montecucco, C, Lauwerys, B, Ng, N, Ho, P, Bombardieri, M, Romão, VC, Verschueren, P, Kelly, S, Sainaghi, PP, Gendi, N, Dasgupta, B, Cauli, A, Reynolds, P, Cañete, JD, Moots, R, Taylor, P, Edwards, CJ, Isaacs, J, Sasieni, P, Choy, E, Pitzalis, C

Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomise... by Rivellese, F, Nerviani, A, Giorli, G, Warren, L, Jaworska, E, Bombardieri, M, Lewis, MJ, Humby, F, Pratt, AG, Filer, A, Gendi, N, Cauli, A, Choy, E, McInnes, I, Durez, P, Edwards, CJ, Buch, MH, Gremese, E, Taylor, PC, Ng, N, Cañete, JD, Raizada, S, McKay, ND, Jadon, D, Sainaghi, PP, Stratton, R, Ehrenstein, M, Ho, P, Pereira, JP, Dasgupta, B, Gorman, C, Galloway, J, Chinoy, H, van der Heijde, D, Sasieni, P, Barton, A, Pitzalis, C